[Congressional Record Volume 167, Number 207 (Wednesday, December 1, 2021)]
[Extensions of Remarks]
[Page E1291]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]





SUPPORTING THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH AND THE 
    REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION ACT

                                 ______
                                 

                               speech of

                           HON. ANNA G. ESHOO

                             of california

                    in the house of representatives

                       Tuesday, November 30, 2021

  Ms. ESHOO. Mr. Speaker, I rise in strong support of H.R. 3743, the 
``Supporting the Foundation for the National Institutes of Health and 
the Reagan-Udall Foundation for the Food and Drug Administration Act,'' 
bipartisan legislation I'm proud to co-lead with Rep. Hudson.


 =========================== NOTE =========================== 

  
  December 1, 2021, on page E1291, in the first column, the 
following appeared: SUPPORTING THE FOUNDATION FOR THE NATIONAL 
INSTITUTES OF HEALTH AND THE REAGAN-UDALL FOUNDATION FOR THE FOOD 
AND DRUG ADMINISTRATION ACT ---------- HON. ANNA G. ESHOO OF 
CALIFORNIA IN THE HOUSE OF REPRESENTATIVES Wednesday, December 1, 
2021 Ms. ESHOO. Mr. Speaker, I rise in strong
  
  The online version has been corrected to read: SUPPORTING THE 
FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH AND THE REAGAN-
UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION ACT --------
-- SPEECH OF HON. ANNA G. ESHOO OF CALIFORNIA IN THE HOUSE OF 
REPRESENTATIVES Tuesday, November 30, 2021 Ms. ESHOO. Mr. Speaker, 
I rise in strong


 ========================= END NOTE ========================= 


  The Foundation for the National Institutes of Health (FNIH) and the 
Reagan-Udall Foundation for the Food and Drug Administration (FDA) are 
exemplary models on how to align public and private partners around a 
common cause, to advance breakthroughs in biomedical discoveries.
  The FNIH organizes key research partnerships to address critical 
issues of our time such as cancer, Alzheimer's disease, and global 
health. Since its formation in 1990, the FNIH has established the 
Accelerating Medicines Partnership program, the Biomarkers Consortium, 
the Alzheimer's Disease Neuroimaging Initiative, and the GeneConvene 
Global Collaborative. Most recently, the FNIH helped to address the 
pandemic by launching and coordinating the Accelerating COVID-19 
Therapeutic Interventions and Vaccines initiative in partnership with 
numerous government agencies, not-for-profit organizations, and 
biopharmaceutical companies. This initiative played a significant role 
in speeding the availability of the highly effective Moderna mRNA 
vaccine.
  The Reagan-Udall Foundation creates robust public-private 
partnerships to advance research and innovation, enhance medical 
decision-making, and empower patients and advocates. The Foundation 
also helps patients navigate clinical trials, benefit from the expanded 
access process, and participate in Listening Sessions with the FDA to 
provide their personal insights about the challenges of living with a 
specific disease.
  H.R. 3743 ensures that these foundations continue to have the 
resources needed for their important work. This legislation increases 
the amount of funding the NIH and the FDA can transfer and allocate to 
their respective foundations.
  These foundations make contributions to biomedical research every day 
and I'm pleased to co-lead H.R. 3743 and urge my colleagues to support 
it.

                          ____________________